Biotechnology Stocks I Performance Guide: Halozyme Therapeutics, Inc. (HALO)
HALO has no dividends.
Table and Chart of HALO Performance
See what a $1,000 investment in HALO is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| HALO Returns | |
|---|---|
| Start Date | May-30-2014 |
| Start Price | $7.90 |
| End Date | May-10-2024 |
| End Price | $43.15 |
| # Prices | 121 |
| Min Date | May-30-2014 |
| Min Price | $7.90 |
| Max Date | Nov-30-2022 |
| Max Price | $57.26 |
| Total Return | 446.20% |
| Annualized Return | 18.34% |
| Current Value of $1,000 Purchase | $5,462 |
| Number Returns | 7,260 |
| Average Return | 105.59% |
| Number Profitable Returns | 5,957 |
| Percent Profitable Returns | 82.05% |
| Number Unprofitable Returns | 1,303 |
| Percent Unprofitable Returns | 17.95% |
| Profitable to Unprofitable Returns Ratio | 4.57 |
| HALO Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $5,491,873,000 |
| Beta | 1.261 | Price to Sales | 5.92 |
| Earnings per Share | $2.4100 |
| PE Ratio | 17.9 |
| PE to Growth Ratio | -2.5 |
| Price to Book | 58.55 |
| PRICE DATA | |
| 52 Week High | $45 |
| 52 Week Low | $31.86 |
| Analyst Target Price | $51.78 |
| 50-Day Moving Average | $40.22 |
| 200-Day Moving Average | $38.79 |
| FINANCIAL DATA | |
| Revenue per Share | $6.64 |
| Revenue | $862,989,000 |
| Profit Margin | 36.9% |
| Return on Equity | 261.7% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
HALO Compare Returns with S&P 500
HALO Trendline Chart
HALO Moving Average Chart
HALO Stock Return Map - See Patterns of Gains and Losses
HALO Stock Returns/Purchase Dates